Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma.
Lectin-recognizable colloidal dispersions stabilized by n-dodecyl beta-D-maltoside: particle-particle and particle-surface interactions.
Prevalence and impact of initial misclassification of pediatric type 1 diabetes mellitus.
Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors.
Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014 Nov 01; 74(21):6048-59.
View in:
PubMed
subject areas
5'-Nucleotidase
Animals
Antigens, CD
Apyrase
Cell Line, Tumor
Gene Expression Regulation, Neoplastic
GPI-Linked Proteins
Humans
Immune Tolerance
Immunotherapy, Adoptive
Interleukin-1beta
Mice
Neoplasms
Th17 Cells
Transforming Growth Factor beta
authors with profiles
Shikhar Mehrotra
Chrystal Mary Paulos
Xuezhong Yu
Chenthamarakshan Vasu
Andrew S Kraft